 | • レポートコード：QY20ST-02016 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の獣医感染症治療市場について種類別（抗生物質、抗ウイルス剤、抗真菌剤、除草剤、駆虫剤）、用途別（ぶた、鶏、犬、猫、牛、馬、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・獣医感染症治療市場の概要 ・世界の主要地域別獣医感染症治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の獣医感染症治療市場規模2015-2026：種類別（抗生物質、抗ウイルス剤、抗真菌剤、除草剤、駆虫剤） ・世界の獣医感染症治療市場規模2015-2026：用途別（ぶた、鶏、犬、猫、牛、馬、その他） ・獣医感染症治療の北米市場規模2015-2020 ・獣医感染症治療のヨーロッパ市場規模2015-2020 ・獣医感染症治療の中国市場規模2015-2020 ・獣医感染症治療の日本市場規模2015-2020 ・獣医感染症治療の東南アジア市場規模2015-2020 ・獣医感染症治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・獣医感染症治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・獣医感染症治療の市場動向・機会・課題 ・調査の結論 |
Veterinary infectious disease is a disease that can be transmitted from one animal to another or from another human being by pathogenic microorganisms.If not treated, will quickly infect animals, animals, will directly result in dairy, food and beverage industry, textile industry future risk, to food service industry, food industry, and families have a negative impact, not only pose a threat to animal veterinary infectious diseases, and pose a threat to humans, their treatment is widely used in veterinary hospital, veterinary clinic, the vet pharmacy, scientific research institutes.
Market Analysis and Insights: Global Veterinary Infectious Diseases Therapeutics Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Veterinary Infectious Diseases Therapeutics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Veterinary Infectious Diseases Therapeutics industry.
Based on our recent survey, we have several different scenarios about the Veterinary Infectious Diseases Therapeutics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Veterinary Infectious Diseases Therapeutics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Veterinary Infectious Diseases Therapeutics Scope and Market Size
The global Veterinary Infectious Diseases Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Infectious Diseases Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Veterinary Infectious Diseases Therapeutics market is segmented into
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics
Segment by Application, the Veterinary Infectious Diseases Therapeutics market is segmented into
Swine
Chicken
Dog
Cat
Cow
Horse
Other
The Veterinary Infectious Diseases Therapeutics market is analysed and market size information is provided by regions (countries). Segment by Application, the Veterinary Infectious Diseases Therapeutics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Veterinary Infectious Diseases Therapeutics Market Share Analysis
Veterinary Infectious Diseases Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Veterinary Infectious Diseases Therapeutics business, the date to enter into the Veterinary Infectious Diseases Therapeutics market, Veterinary Infectious Diseases Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Elanco Animal Health
Novartis Animal Health
Merck
Pfizer Animal Health
Sanofi
Boehringer Ingelheim Vetmedica
Dechra Animal Health
Ceva Sante Animale
Elanco Animal Health
Virbac
1 Veterinary Infectious Diseases Therapeutics Market Overview
1.1 Veterinary Infectious Diseases Therapeutics Product Scope
1.2 Veterinary Infectious Diseases Therapeutics Segment by Type
1.2.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2026)
1.2.2 Antibiotics
1.2.3 Antiviral
1.2.4 Antifungal
1.2.5 Amebicides
1.2.6 Anthelmintics
1.3 Veterinary Infectious Diseases Therapeutics Segment by Application
1.3.1 Global Veterinary Infectious Diseases Therapeutics Sales Comparison by Application (2020-2026)
1.3.2 Swine
1.3.3 Chicken
1.3.4 Dog
1.3.5 Cat
1.3.6 Cow
1.3.7 Horse
1.3.8 Other
1.4 Veterinary Infectious Diseases Therapeutics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2015-2026)
1.4.2 Global Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2015-2026)
1.4.3 Global Veterinary Infectious Diseases Therapeutics Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Veterinary Infectious Diseases Therapeutics Industry Impact
1.5.1 How the Covid-19 is Affecting the Veterinary Infectious Diseases Therapeutics Industry
1.5.1.1 Veterinary Infectious Diseases Therapeutics Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Veterinary Infectious Diseases Therapeutics Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Veterinary Infectious Diseases Therapeutics Players to Combat Covid-19 Impact
2 Veterinary Infectious Diseases Therapeutics Estimate and Forecast by Region
2.1 Global Veterinary Infectious Diseases Therapeutics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Veterinary Infectious Diseases Therapeutics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2015-2020)
2.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2015-2020)
2.3 Global Veterinary Infectious Diseases Therapeutics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Veterinary Infectious Diseases Therapeutics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Veterinary Infectious Diseases Therapeutics Estimates and Projections (2015-2026)
2.4.2 Europe Veterinary Infectious Diseases Therapeutics Estimates and Projections (2015-2026)
2.4.3 China Veterinary Infectious Diseases Therapeutics Estimates and Projections (2015-2026)
2.4.4 Japan Veterinary Infectious Diseases Therapeutics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Veterinary Infectious Diseases Therapeutics Estimates and Projections (2015-2026)
2.4.6 India Veterinary Infectious Diseases Therapeutics Estimates and Projections (2015-2026)
3 Global Veterinary Infectious Diseases Therapeutics Competition Landscape by Players
3.1 Global Top Veterinary Infectious Diseases Therapeutics Players by Sales (2015-2020)
3.2 Global Top Veterinary Infectious Diseases Therapeutics Players by Revenue (2015-2020)
3.3 Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Infectious Diseases Therapeutics as of 2019)
3.4 Global Veterinary Infectious Diseases Therapeutics Average Price by Company (2015-2020)
3.5 Manufacturers Veterinary Infectious Diseases Therapeutics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Veterinary Infectious Diseases Therapeutics Players (Opinion Leaders)
4 Global Veterinary Infectious Diseases Therapeutics Market Size by Type
4.1 Global Veterinary Infectious Diseases Therapeutics Historic Market Review by Type (2015-2020)
4.1.1 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
4.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2015-2020)
4.1.3 Global Veterinary Infectious Diseases Therapeutics Price by Type (2014-2020)
4.2 Global Veterinary Infectious Diseases Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2021-2026)
5 Global Veterinary Infectious Diseases Therapeutics Market Size by Application
5.1 Global Veterinary Infectious Diseases Therapeutics Historic Market Review by Application (2015-2020)
5.1.1 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
5.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2015-2020)
5.1.3 Global Veterinary Infectious Diseases Therapeutics Price by Application (2015-2020)
5.2 Global Veterinary Infectious Diseases Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2021-2026)
3 North America Veterinary Infectious Diseases Therapeutics Market Facts & Figures
3.2 North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
3.3 North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
3.4 North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
4 Europe Veterinary Infectious Diseases Therapeutics Market Facts & Figures
4.2 Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
4.3 Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
4.4 Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
5 China Veterinary Infectious Diseases Therapeutics Market Facts & Figures
5.2 China Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
5.3 China Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
5.4 China Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
6 Japan Veterinary Infectious Diseases Therapeutics Market Facts & Figures
6.2 Japan Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
6.3 Japan Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
6.4 Japan Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
7 Southeast Asia Veterinary Infectious Diseases Therapeutics Market Facts & Figures
7.2 Southeast Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
8 India Veterinary Infectious Diseases Therapeutics Market Facts & Figures
8.2 India Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
8.3 India Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
8.4 India Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Veterinary Infectious Diseases Therapeutics Business
12.1 Elanco Animal Health
12.1.1 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Corporation Information
12.1.2 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
12.1.5 Elanco Animal Health Recent Development
12.2 Novartis Animal Health
12.2.1 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Corporation Information
12.2.2 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
12.2.5 Novartis Animal Health Recent Development
12.3 Merck
12.3.1 Merck Veterinary Infectious Diseases Therapeutics Corporation Information
12.3.2 Merck Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Veterinary Infectious Diseases Therapeutics Products Offered
12.3.5 Merck Recent Development
12.4 Pfizer Animal Health
12.4.1 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Corporation Information
12.4.2 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
12.4.5 Pfizer Animal Health Recent Development
12.5 Sanofi
12.5.1 Sanofi Veterinary Infectious Diseases Therapeutics Corporation Information
12.5.2 Sanofi Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Products Offered
12.5.5 Sanofi Recent Development
12.6 Boehringer Ingelheim Vetmedica
12.6.1 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Corporation Information
12.6.2 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Products Offered
12.6.5 Boehringer Ingelheim Vetmedica Recent Development
12.7 Dechra Animal Health
12.7.1 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Corporation Information
12.7.2 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
12.7.5 Dechra Animal Health Recent Development
12.8 Ceva Sante Animale
12.8.1 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Corporation Information
12.8.2 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Products Offered
12.8.5 Ceva Sante Animale Recent Development
12.9 Elanco Animal Health
12.9.1 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Corporation Information
12.9.2 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
12.9.5 Elanco Animal Health Recent Development
12.10 Virbac
12.10.1 Virbac Veterinary Infectious Diseases Therapeutics Corporation Information
12.10.2 Virbac Veterinary Infectious Diseases Therapeutics Business Overview and Total Revenue
12.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Virbac Veterinary Infectious Diseases Therapeutics Products Offered
12.10.5 Virbac Recent Development
13 Veterinary Infectious Diseases Therapeutics Manufacturing Cost Analysis
13.1 Veterinary Infectious Diseases Therapeutics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Veterinary Infectious Diseases Therapeutics
13.4 Veterinary Infectious Diseases Therapeutics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Veterinary Infectious Diseases Therapeutics Distributors List
14.3 Veterinary Infectious Diseases Therapeutics Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Veterinary Infectious Diseases Therapeutics Sales (KG) Growth Rate by Type (2020-2026)
Table 2. Global Veterinary Infectious Diseases Therapeutics Sales (KG) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Veterinary Infectious Diseases Therapeutics Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Veterinary Infectious Diseases Therapeutics Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Veterinary Infectious Diseases Therapeutics Players to Combat Covid-19 Impact
Table 8. Global Market Veterinary Infectious Diseases Therapeutics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Veterinary Infectious Diseases Therapeutics Sales (KG) by Region (2015-2020)
Table 10. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2015-2020)
Table 11. Global Veterinary Infectious Diseases Therapeutics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Region (2015-2020)
Table 13. Global Veterinary Infectious Diseases Therapeutics Sales (KG) Forecast by Region (2021-2026)
Table 14. Global Veterinary Infectious Diseases Therapeutics Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Veterinary Infectious Diseases Therapeutics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Veterinary Infectious Diseases Therapeutics Revenue Share Forecast by Region (2021-2026)
Table 17. Global Veterinary Infectious Diseases Therapeutics (KG) of Key Companies (2015-2020)
Table 18. Global Veterinary Infectious Diseases Therapeutics Sales Share by Company (2015-2020)
Table 19. Global Veterinary Infectious Diseases Therapeutics Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Company (2015-2020)
Table 21. Global Veterinary Infectious Diseases Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Infectious Diseases Therapeutics as of 2019)
Table 22. Global Veterinary Infectious Diseases Therapeutics Average Price (USD/KG) of Key Company (2015-2020)
Table 23. Manufacturers Veterinary Infectious Diseases Therapeutics Manufacturing Sites and Area Served
Table 24. Manufacturers Veterinary Infectious Diseases Therapeutics Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Veterinary Infectious Diseases Therapeutics Players
Table 27. Global Veterinary Infectious Diseases Therapeutics Sales (KG) by Type (2015-2020)
Table 28. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2015-2020)
Table 29. Global Veterinary Infectious Diseases Therapeutics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Veterinary Infectious Diseases Therapeutics Price (KG) by Type (2015-2020)
Table 31. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2021-2026)
Table 32. Global Veterinary Infectious Diseases Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2021-2026)
Table 34. Global Veterinary Infectious Diseases Therapeutics Price (KG) by Type (2021-2026)
Table 35. Global Veterinary Infectious Diseases Therapeutics Sales (KG) by Application (2015-2020)
Table 36. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2015-2020)
Table 37. Global Veterinary Infectious Diseases Therapeutics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Veterinary Infectious Diseases Therapeutics Price (KG) by Application (2015-2020)
Table 39. Global Veterinary Infectious Diseases Therapeutics Sales (KG) by Application (2021-2026)
Table 40. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2021-2026)
Table 41. Global Veterinary Infectious Diseases Therapeutics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2021-2026)
Table 43. Global Veterinary Infectious Diseases Therapeutics Price (KG) by Application (2021-2026)
Table 44. United States Veterinary Infectious Diseases Therapeutics Sales (KG) by Company (2015-2020)
Table 45. United States Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
Table 46. United States Veterinary Infectious Diseases Therapeutics Sales (KG) by Type (2015-2020)
Table 47. United States Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
Table 48. United States Veterinary Infectious Diseases Therapeutics Sales (KG) by Application (2015-2020)
Table 49. United States Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
Table 50. Europe Veterinary Infectious Diseases Therapeutics Sales (KG) by Company (2015-2020)
Table 51. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
Table 52. Europe Veterinary Infectious Diseases Therapeutics Sales (KG) by Type (2015-2020)
Table 53. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
Table 54. Europe Veterinary Infectious Diseases Therapeutics Sales (KG) by Application (2015-2020)
Table 55. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
Table 56. China Veterinary Infectious Diseases Therapeutics Sales (KG) by Company (2015-2020)
Table 57. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
Table 58. China Veterinary Infectious Diseases Therapeutics Sales (KG) by Type (2015-2020)
Table 59. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
Table 60. China Veterinary Infectious Diseases Therapeutics Sales (KG) by Application (2015-2020)
Table 61. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
Table 62. Japan Veterinary Infectious Diseases Therapeutics Sales (KG) by Company (2015-2020)
Table 63. Japan Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
Table 64. Japan Veterinary Infectious Diseases Therapeutics Sales (KG) by Type (2015-2020)
Table 65. Japan Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
Table 66. Japan Veterinary Infectious Diseases Therapeutics Sales (KG) by Application (2015-2020)
Table 67. Japan Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales (KG) by Company (2015-2020)
Table 69. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales (KG) by Type (2015-2020)
Table 71. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales (KG) by Type (2015-2020)
Table 73. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
Table 74. India Veterinary Infectious Diseases Therapeutics Sales (KG) by Company (2015-2020)
Table 75. India Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2015-2020)
Table 76. India Veterinary Infectious Diseases Therapeutics Sales (KG) by Type (2015-2020)
Table 77. India Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2015-2020)
Table 78. India Veterinary Infectious Diseases Therapeutics Sales (KG) by Application (2015-2020)
Table 79. India Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2015-2020)
Table 80. Elanco Animal Health Corporation Information
Table 81. Elanco Animal Health Description and Business Overview
Table 82. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 83. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product
Table 84. Elanco Animal Health Recent Development
Table 85. Novartis Animal Health Corporation Information
Table 86. Novartis Animal Health Description and Business Overview
Table 87. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 88. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product
Table 89. Novartis Animal Health Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 93. Merck Veterinary Infectious Diseases Therapeutics Product
Table 94. Merck Recent Development
Table 95. Pfizer Animal Health Corporation Information
Table 96. Pfizer Animal Health Description and Business Overview
Table 97. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 98. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product
Table 99. Pfizer Animal Health Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 103. Sanofi Veterinary Infectious Diseases Therapeutics Product
Table 104. Sanofi Recent Development
Table 105. Boehringer Ingelheim Vetmedica Corporation Information
Table 106. Boehringer Ingelheim Vetmedica Description and Business Overview
Table 107. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 108. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product
Table 109. Boehringer Ingelheim Vetmedica Recent Development
Table 110. Dechra Animal Health Corporation Information
Table 111. Dechra Animal Health Description and Business Overview
Table 112. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 113. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product
Table 114. Dechra Animal Health Recent Development
Table 115. Ceva Sante Animale Corporation Information
Table 116. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 117. Ceva Sante Animale Description and Business Overview
Table 118. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product
Table 119. Ceva Sante Animale Recent Development
Table 120. Elanco Animal Health Corporation Information
Table 121. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 122. Elanco Animal Health Description and Business Overview
Table 123. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product
Table 124. Elanco Animal Health Recent Development
Table . Virbac Corporation Information
Table . Virbac Description and Business Overview
Table . Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table . Virbac Veterinary Infectious Diseases Therapeutics Product
Table . Virbac Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Veterinary Infectious Diseases Therapeutics Distributors List
Table 133. Veterinary Infectious Diseases Therapeutics Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Infectious Diseases Therapeutics Product Picture
Figure 2. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Veterinary Infectious Diseases Therapeutics Market Share by Application in 2020 & 2026
Figure 6. Swine Examples
Figure 7. Chicken Examples
Figure 8. Dog Examples
Figure 9. Cat Examples
Figure 10. Cow Examples
Figure 11. Horse Examples
Figure 12. Other Examples
Figure 13. Global Veterinary Infectious Diseases Therapeutics Sales (KG) Growth Rate (2015-2026)
Figure 14. Global Veterinary Infectious Diseases Therapeutics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 15. Global Veterinary Infectious Diseases Therapeutics Price Trends Growth Rate (2015-2026) (USD/KG)
Figure 16. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region: 2015 VS 2020
Figure 17. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region: 2021 VS 2026
Figure 18. United States Veterinary Infectious Diseases Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. United States Veterinary Infectious Diseases Therapeutics Sales (KG) Growth Rate (2015-2026)
Figure 20. Europe Veterinary Infectious Diseases Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Europe Veterinary Infectious Diseases Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 22. China Veterinary Infectious Diseases Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. China Veterinary Infectious Diseases Therapeutics Sales (Million USD) and Growth Rate (2015-2026)
Figure 24. Japan Veterinary Infectious Diseases Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Japan Veterinary Infectious Diseases Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 28. India Veterinary Infectious Diseases Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. India Veterinary Infectious Diseases Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 30. Global 5 Largest Veterinary Infectious Diseases Therapeutics Players Market Share by Revenue in Veterinary Infectious Diseases Therapeutics 2015 & 2019
Figure 31. Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 32. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2015-2020)
Figure 33. Global Veterinary Infectious Diseases Therapeutics Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2015-2020)
Figure 35. Global Veterinary Infectious Diseases Therapeutics Revenue Growth Rate by Application in 2015 & 2019
Figure 36. United States Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2019
Figure 37. United States Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2019
Figure 38. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Company in 2019
Figure 39. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2019
Figure 40. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application in 2019
Figure 41. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Company in 2019
Figure 42. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2019
Figure 43. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Application in 2019
Figure 44. Japan Veterinary Infectious Diseases Therapeutics Sales Market Share by Company in 2019
Figure 45. Japan Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2019
Figure 46. Japan Veterinary Infectious Diseases Therapeutics Sales Market Share by Application in 2019
Figure 47. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Company in 2019
Figure 48. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2019
Figure 49. Southeast Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Application in 2019
Figure 50. India Veterinary Infectious Diseases Therapeutics Sales Market Share by Company in 2019
Figure 51. India Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2019
Figure 52. India Veterinary Infectious Diseases Therapeutics Sales Market Share by Application in 2019
Figure 53. Elanco Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novartis Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Pfizer Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Boehringer Ingelheim Vetmedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Dechra Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Elanco Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Virbac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Veterinary Infectious Diseases Therapeutics
Figure 65. Manufacturing Process Analysis of Veterinary Infectious Diseases Therapeutics
Figure 66. Veterinary Infectious Diseases Therapeutics Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
獣医用ウェルネスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Veterinary Wellness market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- モノクローナル抗体治療剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Monoclonal Antibody Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 146500 million by 2025, from USD 112440 million in 2019. The Mon…
- 獣医クリニックサービスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Veterinary Clinics Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Veterinary Clinic…
- mRNA癌ワクチン及び治療剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Cancer Vaccines and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- mRNA癌ワクチン及び治療剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Cancer Vaccines and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…